Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Oxymorphone, sold under the brand names Numorphan and Opana among others, is a highly potent opioid analgesic indicated for treatment of severe pain. Pain relief after injection begins after about 5–10 minutes; after oral administration it begins after about 30 minutes and lasts about 3–4 hours for immediate-release tablets and 12 hours for…
Community, Culture & Applications
Explore the main themes, entities and connections around Oxymorphone. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
opioid opana pain drug er abuse us fda use opioids endo risk outbreak due extended-release pharmaceuticals oxycodone needed hiv injection
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Oxymorphone | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Oxymorphone | Addiction liability | High | 1.00 | infobox |
| Oxymorphone | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Oxymorphone | ATC code | N02AA11 (WHO) | 1.00 | infobox |
| Oxymorphone | Bioavailability | By mouth: 10% Buccal: 28% Sublingual: 37.5% Intranasal: 43% IV/IM/IT: 100% | 1.00 | infobox |
| Oxymorphone | CAS Number | 76-41-5 Y | 1.00 | infobox |
| Oxymorphone | ChEMBL | ChEMBL963 Y | 1.00 | infobox |
| Oxymorphone | ChemSpider | 4447650 Y | 1.00 | infobox |
| Oxymorphone | CompTox Dashboard (EPA) | DTXSID5023409 | 1.00 | infobox |
| Oxymorphone | Dependence liability | High | 1.00 | infobox |
| Oxymorphone | Drug class | Opioid | 1.00 | infobox |
| Oxymorphone | DrugBank | DB01192 Y | 1.00 | infobox |
| Oxymorphone | Duration of action | By mouth: 6–8 hours Parenteral: 4–6 hours | 1.00 | infobox |
| Oxymorphone | ECHA InfoCard | 100.000.873 | 1.00 | infobox |
| Oxymorphone | Elimination half-life | 10–12 hours | 1.00 | infobox |
| Oxymorphone | Excretion | Urine, feces | 1.00 | infobox |
| Oxymorphone | Formula | C17H19NO4 | 1.00 | infobox |
| Oxymorphone | IUPHAR/BPS | 7094 | 1.00 | infobox |
| Oxymorphone | KEGG | D08323 Y | 1.00 | infobox |
| Oxymorphone | Legal status | AU: S8 (Controlled drug) | 1.00 | infobox |
| Oxymorphone | Legal status | BR: Class A1 (Narcotic drugs) | 1.00 | infobox |
| Oxymorphone | Legal status | CA: Schedule I | 1.00 | infobox |
| Oxymorphone | Legal status | DE: Anlage II (Authorized trade only, not prescriptible) | 1.00 | infobox |
| Oxymorphone | Legal status | UK: Class A | 1.00 | infobox |
| Oxymorphone | Legal status | US: Schedule II | 1.00 | infobox |
| Oxymorphone | License data | US DailyMed: Oxymorphone | 1.00 | infobox |
| Oxymorphone | MedlinePlus | a610022 | 1.00 | infobox |
| Oxymorphone | Metabolism | Liver (CYP3A4, glucuronidation) | 1.00 | infobox |
| Oxymorphone | Metabolites | • Noroxymorphone • glucuronide | 1.00 | infobox |
| Oxymorphone | Molar mass | 301.342 g·mol−1 | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.